Biotech China 2014

Biology: University of Texas, MD Anderson

Total Score People Score Events Score
114 85 49
Date Event Presentation Speakers
June 24, 2014 Microbiology after the Genomics Revolution (Genomes 2014) Session 7: Host genetics and model systems George Weinstock
May 23, 2014 (E2) Keystone Symposia: Autophagy: Fundamentals to Disease Autophagy and Disease Registered attendees can view abstracts starting on 04/23/2014 Beth Levine
March 19, 2014 3rd Neurological Biomarkers Chairperson's Introduction Andreas Jeromin
February 4, 2014 Cancer Epigenetics (Q1) Fundamentals at the Structural, Biochemical and Genomic Levels (Joint) Registered attendees can view abstracts starting on 01/04/2014 SHARON ROTH DENT
Histone Modifiers in Development and Cancer Registered attendees can view abstracts starting on 01/04/2014 Sharon Dent
January 19, 2014 (J5) Keystone Symposia: Pathogenesis of Respiratory Viruses Signaling Responses to Virus Infection Registered attendees can view abstracts starting on 12/19/2013 Yong-Jun Liu
January 17, 2014 (J3) Keystone Symposia: Emerging Cytokine Networks New Targets and Treatment in Allergic Diseases Yong-Jun Liu
May 31, 2013 ASCO Annual Meeting 2013 Management of Chronic Lymphocytic Leukemia (M10) William G. Wierda
Education Sessions Anas Younes
Education Sessions John de Groot
Special Session Razelle Kurzrock, Gabriel N Hortobagyi
Education Sessions Robert L. Coleman
Educations Sessions Jeffrey E Gershenwald, Stanley Hamilton
May 1, 2013 SymposiumonAdvancedWoundCareSpringandWoundHealingSociety (7 Concurrent Sessions - choose one) Caroline E. Fife
(6 Concurrent Sessions - choose one) Caroline E. Fife
(6 Concurrent Sessions - choose one) Caroline E. Fife
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Biochemical Characterization of Nucleic Acid Sensors in Dendritic Cells Yong-Jun Liu
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium The Practical Use of Molecular Profiling – Ballroom A Lajos Pusztai, Peter M. Ravdin
William L. McGuire Memorial Lecture – Exhibit Hall D Neoadjuvant System Therapy: Promising Experimental Model, or Improved Standard of Care? Gabriel N Hortobagyi
Mini-Symposium 2 - Exhibit Hall D Breast Density: Mechanisms and Clinical Implications Melissa L Bondy
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Genomic alterations in gingivobuccal cancer: Results from whole-exome resequencing Sadhan Majumder
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation Raymond N DuBois
Plenary Session 5 | Cancer Prevention and Chemoprevention Raymond N DuBois
Day in Review Raymond N DuBois
Session 4 | Molecular Epidemiology of Cancer: Towards Personalized Risk Assessment, Prevention, and Therapy Xifeng Wu
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease Dynamics and dimerization in TGF-beta signal transduction Andrew P. Hinck
July 28, 2011 International Conference on Biomedical Ontology The Ontology of Microbial Phenotypes (OMP) | A Precomposed Ontology Based on Cross Products from Multiple External Ontologies that is Used for Guiding Microbial Phenotype Annotation Deborah Siegele
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis MicroRNA-200 | A Sensor of the Extracellular Milieu and Regulator of Metastasis Jonathan M. Kurie,
May 15, 2011 Lipid Biology and Lipotoxicity (E2) Origins of the Lipotoxicity Hypothesis | Implications for Human Disease Roger Unger
Talk Title to be Determined Philipp Scherer
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Characterization of new post-transcriptional regulators of fatty acid synthesis Jay Horton
March 9, 2011 28th Annual Miami Breast Cancer Conferenceâ„¢ Nipple Discharge and Gynecomastia Henry Kuerer
Histologic and Biologic Markers to Differentiate Indolent From Aggressive DCIS Henry Kuerer
Is There a Role for Preoperative Therapy in DCIS? Henry Kuerer
Session B | Can We Personalize Adjuvant Chemotherapy? William F. Symmans
Predicting Survival From Adjuvant Therapy William F. Symmans
Breast Cancer Brain Metastasis | "The Seed and the Soil" Isaiah J. Fidler
Session B | "Meet the Professor" Sessions William F. Symmans
Roundtable Discussion With Audience Participation on Current Issues in Breast Cancer | Follow-up, Treatment Side Effects, Costs, End-of-Life Care, and "Burn-Out" William F. Symmans
Biomarkers for Resistance in Residual Tumor William F. Symmans
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Th17 Cells Contribute to Intestinal Homeostasis by Inducing Intestinal IgA and pIgR Expression Anthony Cao
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma How I Manage Relapsed/Refractory Chronic Lymphocytic Leukemia William G. Wierda
Comment William G. Wierda
HDAC Function and HDAC Inhibitors: Where Is the Selectivity? Jean-Pierre Issa
Epigenetics and the Biology of Hematologic Malignancies Anas Younes
Afternoon Workshop | Epigenetics and Gene Expression Anas Younes
Comment Jean-Pierre Issa
The Nature of Future MoAbs in Leukemia William G. Wierda
Non-Hodgkin Lymphoma: Conjugated and Nonconjugated MoAbs Anas Younes
Chronic Lymphocytic Leukemia William G. Wierda
Acute Myeloid Leukemia | Myelodysplastic Syndromes Jean-Pierre Issa
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) PI 3-Kinases (X2) | Workshop 1: Monitoring Phosphoinositide Activation in Signaling and Disease Gordon Mills
PI 3-Kinases (X2) | A Systems Biology Approach to Monitor the PI3K Pathway Gordon Mills
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Plasmacytoid DC in Cancer Yong-Jun Liu
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Ligand-directed targeting and nanotechnology: Discovery and translational updates Renata Pasqualini
Targeted gold nanoparticles and non-invasive RF treatment for cancer Steven A Curley
Title to be announced Mauro Ferrari
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Adipose Tissue Factors: Modulators of Insulin Sensitivity, Inflammation and Apoptosis | Columbine Ballroom Philipp Scherer
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Philipp Scherer
January 12, 2011 Obesity (J2) Adipose Tissue Factors: Modulators of Insulin Sensitivity, Inflammation and Apoptosis | Columbine Ballroom Philipp Scherer
In Search of Targets for Restoring beta-cell Function | Columbine Ballroom Philipp Scherer
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Interpretation of biomarker studies Lajos Pusztai
MicroRNA in medical practice George A. Calin
Cancers are stressed too: exploiting cancer stress for new therapies Garth Powis
November 3, 2010 Eighth Annual RNAi for Functional Screens A Comprehensive Strategy From RNAi Screening, Through Validation, Genomic Analysis, Comparative Biology to Biological Target Alex Bishop
October 27, 2010 Colorectal Cancer: Biology to Therapy Inflammation and cancer: Impact of COX-2 and other inflammatory mediators Raymond N DuBois
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Therapy of Cancer Metastasis: Attacking the Stroma Isaiah J. Fidler
The Biology of Cancer Metastasis Isaiah J. Fidler
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Lipid-protein interactions as a determinant of membrane protein structure and function William Dowhan
Sterol analysis in mammalian cells and tissues David Russell
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis Systems Approach to Biomarker Identification Gordon Mills
February 28, 2009 Biophysical Society 53rd Annual Meeting Symposium 1: Protein Modularity and Flexibility in Signal Transduction Mike Rosen
Symposium 9: Sensing the Membrane William Dowhan
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Concurrent D: COMP-specific Ribozyme: A New Strategy for Gene Therapy Joseph Alcorn
Concurrent E: Modeling single and collective cell movements in 3D matrices Muhammad H. Zaman
Junior Investigator Awardee: Fibulins: Implications in Vascular Development and Disease Hiromi Yanagisawa
Concurrent H: Skeletal abnormalities in quad- KO mice (TSP1, 3, 5, and Col 9) Karen Posey,
Concurrent N: Postnatal Ablation of Sox9 in Mouse Cartilage Stephen Henry,
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
September 29, 2008 Biomarker Data Analysis Chairperson’s Opening Remarks George A. Calin
High-Throughput Functional Proteomics Facilitates a Systems Biology Approach to Personalized Medicine Gordon Mills
Semantic Web Abstractions for Biomedical Informatics: A Better Foundation for Integrating Sensitive Heterogeneous Data Sources Jonas S. Almeida
August 18, 2008 Systems Integration in Biodefense Collection, Focusing, and Metering of DNA in Microchannels Using Addressable Electrode Arrays for Portable Low-Power Bioanalysis Victor M Ugaz
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 2: Etiology and Epidemiology of Viral Infections R. Palmer Beasley
Session 3: Epidemiology and Virology Lu-Yu Hwang
Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States Lu-Yu Hwang
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 11: Allosteric Control and Conformational Changes Vincent Hilser
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
March 30, 2008 Nuclear Receptors: Steroid Sisters Differentiation and Development David J. Mangelsdorf
Steroid Receptor Signaling and Dynamics Stephen R. Hammes
Steroid Receptors and Cancer Rakesh Kumar
Workshop 3 - Hot Topics: Chromatin/Transcription Raj Kumar
March 30, 2008 Nuclear Receptors: Orphan Brothers Differentiation and Development David J. Mangelsdorf
Steroid Receptor Signaling and Dynamics Stephen R. Hammes
Steroid Receptors and Cancer Rakesh Kumar
Workshop 3 - Hot Topics: Chromatin/Transcription Raj Kumar
March 25, 2008 PATHWAY ANALYSIS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Monitoring and Manipulating the Proteome With Peptoids Thomas Kodadek
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis PCSK9, a secreted protease with a non-protease function Jay Horton
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Muhammad H. Zaman
Cellular Biology of Gap Junction Channels (Room 103A) Guillermo Altenberg, Srikanth Polusani
Translocon-mediated Head-First Insertion and Rotation of a Signal Anchor during Cotranslational Integration. A E Johnson
Mechanism of the Neurospora Circadian Negative Feedback Loop. Yi Liu
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Madeleine Duvic
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Madeleine Duvic
September 7, 2007 The 2007 Breast Symposium General Session IV: Clinical and Research Issues in Pathology 3:45 PM — 5:30 PM William F. Symmans
General Session V: Local Regional Management 8:00 AM — 9:45 AM Funda Meric Bernstam
Tyrosine-Kinase Inhibitors Francisco J. Esteva
Challenges for Radiation Therapy After Preoperative Therapy Thomas A a Buchholz
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Tissue Genesis and Repair Jacqueline T Hecht
Insights into COMP/TSP5 related causes of abnormal skeletogenesis Jacqueline T Hecht
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.